HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristin Andersen Selected Research

Nuclear Receptor Co-Repressor 2

3/2022Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristin Andersen Research Topics

Disease

9Neoplasms (Cancer)
07/2022 - 01/2003
5Neoplasm Metastasis (Metastasis)
04/2011 - 01/2003
3Breast Neoplasms (Breast Cancer)
01/2014 - 04/2011
3Osteosarcoma (Osteogenic Sarcoma)
08/2004 - 01/2003
1Genetic Translocation (Chromosomal Translocation)
07/2022
1Rhabdomyosarcoma
11/2021
1Leiomyoma (Uterine Fibroids)
07/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Leukemia
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Bone Cysts (Bone Cyst)
09/2020
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
09/2020
1Angiofibroma
09/2020
1Solitary Fibrous Tumors
09/2020
1Pleomorphic Adenoma
05/2020
1Osteoblastoma
09/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018
1Ependymoma
12/2016
1Melanoma (Melanoma, Malignant)
08/2004
1Carcinoma (Carcinomatosis)
01/2003
1Prostatic Neoplasms (Prostate Cancer)
01/2003

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
07/2022 - 12/2016
3Proteins (Proteins, Gene)FDA Link
04/2011 - 12/2003
2Carrier Proteins (Binding Protein)IBA
09/2020 - 08/2004
2Interferon-gamma (Interferon, gamma)IBA
01/2007 - 08/2004
2Matrix Metalloproteinases (MMPs)IBA
12/2003 - 01/2003
2Tissue Inhibitor of Metalloproteinase-2IBA
12/2003 - 01/2003
1Intergenic DNA (Junk DNA)IBA
07/2022
1Nuclear Receptor Co-Repressor 2IBA
03/2022
1Histones (Histone)IBA
03/2022
1P 11 (P-11)IBA
11/2021
1myocardinIBA
11/2021
1Transcription Factors (Transcription Factor)IBA
11/2021
1Topoisomerase II InhibitorsIBA
01/2021
1Ubiquitin-Specific ProteasesIBA
09/2020
1LumicanIBA
09/2020
1Pyridinolcarbamate (P23)IBA
09/2020
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Phenobarbital (Luminal)FDA Link
01/2014
1Biomarkers (Surrogate Marker)IBA
08/2011
1Epithelial Cell Adhesion MoleculeIBA
08/2011
1Indicators and Reagents (Reagents)IBA
04/2011
1S100 Calcium-Binding Protein A4IBA
04/2011
1Calcium-Binding ProteinsIBA
04/2011
1Catalytic RNA (Ribozymes)IBA
08/2004
1Cadherins (E-Cadherin)IBA
08/2004
1Pharmaceutical PreparationsIBA
12/2003
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2003
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2003
1progelatinaseIBA
12/2003
1ColchicineFDA LinkGeneric
12/2003
1Biological ProductsIBA
01/2003
1AndrogensIBA
01/2003
1Metalloproteases (Metalloproteinases)IBA
01/2003

Therapy/Procedure

3Therapeutics
04/2021 - 12/2015